Register Login

ELECTROCORE, INC. (ECOR)

SymbolECOR
NameELECTROCORE, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
Address200 FORGE WAY,SUITE 205, ROCKAWAY, New Jersey, 07866, United States
Telephone+1 973 290-0097
Fax—
Email—
Websitehttps://www.electrocore.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001560258
Description

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The companys product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults.

Additional info from NASDAQ:
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The companys product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults.

2026-05-09 00:00

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

Read more
2026-05-06 20:15

(75% Positive) ELECTROCORE, INC. (ECOR) Reports Q2 2026 Financial Results

Read more
2026-05-05 15:26

New Form SCHEDULE 13G - electroCore, Inc. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0002058477-26-000003 <b>Size:</b> 9 KB

Read more
2026-05-05 14:37

📋 Goldberger Daniel S (Ex-Affiliate) plans to sell 25K shares of electroCore, Inc. (at $6.72 each, total $168K) Filed: May 05, 2026 | ID: 000247

Read more
2026-04-29 12:00

electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026

Read more
2026-04-28 12:00

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

Read more
2026-04-23 16:43

📋 Goldberger Daniel S (Ex-CEO) plans to sell 10K shares of electroCore, Inc. (at $6.13 each, total $61K) Filed: Apr 23, 2026 | ID: 000220

Read more
2026-04-23 12:00

electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

Read more
2026-04-15 17:05

New Form D - electroCore, Inc. <b>Filed:</b> 2026-04-15 <b>AccNo:</b> 0001493152-26-016804 <b>Size:</b> 12 KB

Read more
2026-04-14 20:05

Fox Michael 🟢 acquired 70.0K shares of electroCore, Inc. (ECOR) Transaction Date: Apr 13, 2026 | Filing ID: 016542

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT07523685 Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder … Na PTSD Recruiting 2026-03-02 2027-03-01 ClinicalTrials.gov
NCT05103566 Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS… Na Subarachnoid Hemorrhage, Aneurysmal Recruiting 2022-10-04 2026-04-01 ClinicalTrials.gov
NCT05165108 Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pi… Na Crohn Disease Terminated 2021-11-30 2022-08-12 ClinicalTrials.gov
NCT04935697 Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Ind… Na Acute Respiratory Distress Syndrome Completed 2021-08-04 2025-03-01 ClinicalTrials.gov
NCT04857281 Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nau… Na Chronic Unexplained Nausea and Vomiting Completed 2021-04-19 2024-01-23 ClinicalTrials.gov
NCT04382391 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms Na COVID Terminated 2020-05-15 2023-04-13 ClinicalTrials.gov
NCT04143269 Treatment of Complications to Diabetic Autonomic Neuropathy With Vagus Nerve St… Na Gastrointestinal Dysfunction Completed 2020-01-20 2023-02-01 ClinicalTrials.gov
NCT04071743 Study of Gammacore Sapphire for the Acute and Preventive Treatment of Post-Trau… Na Post-Traumatic Headache Withdrawn 2020-01-01 2021-12-31 ClinicalTrials.gov
NCT04050501 Non-invasive Vagus Nerve Stimulation in Acute Ischemic Stroke Na Ischemic Stroke Completed 2019-10-09 2025-05-05 ClinicalTrials.gov
NCT03787238 A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migr… Na Migraine Withdrawn 2019-05-15 2020-10-01 ClinicalTrials.gov
NCT03733431 Non-invasive TRanscutaneous Cervical Vagus Nerve Stimulation as a Treatment for… Na Stroke, Acute Completed 2019-05-10 2021-04-01 ClinicalTrials.gov
NCT03869008 Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in t… Na Raynaud Phenomenon Terminated 2019-04-30 2020-02-27 ClinicalTrials.gov
NCT03716505 Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines Na Migraine Disorders Completed 2018-11-02 2020-09-09 ClinicalTrials.gov
NCT03357029 Neuromodulation in Patients With Painful Chronic Pancreatitis Na Painful Chronic Pancreatitis Completed 2018-01-11 2019-04-30 ClinicalTrials.gov
NCT02974959 Vagus Nerve Stimulation to Treat Moderate Traumatic Brain Injury Phase1 Traumatic Brain Injury Completed 2016-10-01 2020-11-01 ClinicalTrials.gov
NCT02686034 RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acu… Na Migraine Completed 2016-01-01 2017-03-01 ClinicalTrials.gov
NCT02378844 A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Epi… Na Migraine Completed 2015-06-01 2018-08-29 ClinicalTrials.gov
NCT02388269 A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Stud… Na Dyspepsia Completed 2014-06-01 2015-06-01 ClinicalTrials.gov
NCT01958125 A Randomized Multicentre Study for the Acute Relief of Episodic and Chronic Clu… Na Cluster Headache Completed 2013-08-01 2015-01-01 ClinicalTrials.gov
NCT01910129 Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures … Na Seizure Terminated 2013-07-01 2014-10-01 ClinicalTrials.gov
NCT01792817 Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster H… Na Cluster Headache Completed 2013-02-01 2014-10-01 ClinicalTrials.gov
NCT01612793 Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospi… — Chronic Obstructive Pulmonary Disease Terminated 2012-10-01 2013-04-01 ClinicalTrials.gov
NCT01923272 Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore Device for … Na Asthma Withdrawn 2012-10-01 2012-10-01 ClinicalTrials.gov
NCT01701245 Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard… Phase2 Chronic Cluster Headache Completed 2012-10-01 2014-10-01 ClinicalTrials.gov
NCT01667250 Non-Invasive Neurostimulation for the Prevention of Chronic Migraine Na Chronic Migraine Completed 2012-10-01 2014-05-01 ClinicalTrials.gov
NCT01679314 Study to Compare (COPD) Assessment Test in COPD Stage III and IV in a Prophylac… Na Chronic Obstructive Pulmonary Disease Completed 2012-07-01 2013-05-01 ClinicalTrials.gov
NCT01532830 Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migrai… Na Migraine Completed 2012-02-01 2012-07-25 ClinicalTrials.gov
NCT01532817 Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Dev… Na Asthma Completed 2012-01-01 2012-05-01 ClinicalTrials.gov
NCT03410628 Non-invasive Neurostimulation for the Relief of Migraine Na Migraine Terminated 2011-07-01 2011-12-01 ClinicalTrials.gov
NCT01385306 Noninvasive Neurostimulation of the Vagus Nerve for the Relief of Acute Broncho… Na Asthma Terminated 2011-06-01 2012-07-01 ClinicalTrials.gov
NCT00854074 Neurostimulation for the Treatment of Post-Operative Ileus Na Ileus Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00762931 Neurostimulation for the Relief of Acute Bronchoconstriction Na Asthma Completed 2008-09-01 2010-10-01 ClinicalTrials.gov
Total clinical trials: 32
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
AlphaCore device Device Approved Chronic Obstructive Pulmonary Disease COMPLETED NCT01679314
non-invasive vagus nerve stimulation Other Approved Migraine WITHDRAWN NCT03787238
Sham Device Device Approved Painful Chronic Pancreatitis COMPLETED NCT03357029
GammaCore Device Device Approved Painful Chronic Pancreatitis COMPLETED NCT03357029
AlphaCore Other Approved Asthma WITHDRAWN NCT01923272
AlphaCore Device Device Approved Asthma WITHDRAWN NCT01923272
GammaCore Other Phase PHASE2 Chronic Cluster Headache COMPLETED NCT01701245
gammaCore®-G Other Approved Dyspepsia COMPLETED NCT02388269
AlphaCore Other Approved Asthma COMPLETED NCT01532817
GammaCore Sham Device Device Approved Chronic Migraine COMPLETED NCT01667250
GammaCore Active Device Device Approved Chronic Migraine COMPLETED NCT01667250
n-VNS Other Approved Migraine COMPLETED NCT01532830
gammaCore Other Approved Migraine TERMINATED NCT03410628
AlphaCore System Other Approved Asthma TERMINATED NCT01385306
gammaCore Other Approved Cluster Headache COMPLETED NCT01958125
AlphaCore Device Device Preclinical Chronic Obstructive Pulmonary Disease TERMINATED NCT01612793
gammaCore Other Approved Seizure TERMINATED NCT01910129
gammaCore-S Sham Other Approved Migraine COMPLETED NCT02686034
gammaCore-S Other Approved Migraine COMPLETED NCT02686034
gammaCore®-R Sham Other Approved Migraine COMPLETED NCT02378844
gammaCore®-R Other Approved Migraine COMPLETED NCT02378844
Sham GammaCore device Device Approved Cluster Headache COMPLETED NCT01792817
GammaCore Other Approved Cluster Headache COMPLETED NCT01792817
sham gammaCore Sapphire Other Approved Post-Traumatic Headache WITHDRAWN NCT04071743
gammaCore Sapphire Other Approved Post-Traumatic Headache WITHDRAWN NCT04071743
gammaCore Sapphire Sham Other Approved Migraine Disorders COMPLETED NCT03716505
gammaCore Sapphire active Other Approved Migraine Disorders COMPLETED NCT03716505
gammaCore sham device Device Phase PHASE1 Traumatic Brain Injury COMPLETED NCT02974959
gammaCore active device Device Phase PHASE1 Traumatic Brain Injury COMPLETED NCT02974959
Gammacore sham device Device Approved Stroke, Acute COMPLETED NCT03733431
Gammacore device Device Approved Stroke, Acute COMPLETED NCT03733431
Sham vagus nerve stimulation Other Approved Gastrointestinal Dysfunction COMPLETED NCT04143269
Non-invasive transcutaneous vagus nerve stimulation Other Approved Gastrointestinal Dysfunction COMPLETED NCT04143269
Standard of care therapies Other Approved COVID TERMINATED NCT04382391
gammaCore® Sapphire (non-invasive vagus nerve stimulator) Other Approved COVID TERMINATED NCT04382391
nVNS (gammaCore) Other Approved Chronic Unexplained Nausea and Vomiting COMPLETED NCT04857281
Vagal Nerve Stimulator Other Approved Crohn Disease TERMINATED NCT05165108
gammaCore Other Approved Subarachnoid Hemorrhage, Aneurysmal RECRUITING NCT05103566
non-invasive Vagus Nerve Stimulator Other Approved Ischemic Stroke COMPLETED NCT04050501
Sham Device Device Approved Raynaud Phenomenon TERMINATED NCT03869008
gammaCore Sapphire Other Approved Raynaud Phenomenon TERMINATED NCT03869008
SOC Other Approved Acute Respiratory Distress Syndrome COMPLETED NCT04935697
nVNS Other Approved Acute Respiratory Distress Syndrome COMPLETED NCT04935697
non-invasive vagus nerve stimulation Other Approved PTSD RECRUITING NCT07523685
non-invasive vagus nerve stimulation Other Approved PTSD RECRUITING NCT07523685
non-invasive vagus nerve stimulation Other Approved PTSD RECRUITING NCT07523685
non-invasive vagus nerve stimulation Other Approved PTSD RECRUITING NCT07523685
non-invasive vagus nerve stimulation Other Approved PTSD RECRUITING NCT07523685
non-invasive vagus nerve stimulation Other Approved PTSD RECRUITING NCT07523685
non-invasive vagus nerve stimulation Other Approved PTSD RECRUITING NCT07523685
non-invasive vagus nerve stimulation Other Approved PTSD RECRUITING NCT07523685
Vagal Nerve Stimulator DEVICE Approved Crohn Disease TERMINATED NCT05165108
SOC OTHER Approved Acute Respiratory Distress Syndrome COMPLETED NCT04935697
nVNS DEVICE Approved Acute Respiratory Distress Syndrome COMPLETED NCT04935697
nVNS (gammaCore) DEVICE Approved Chronic Unexplained Nausea and Vomiting COMPLETED NCT04857281
Standard of care therapies OTHER Approved COVID TERMINATED NCT04382391
gammaCore® Sapphire (non-invasive vagus nerve stimulator) DEVICE Approved COVID TERMINATED NCT04382391
Sham vagus nerve stimulation DEVICE Approved Gastrointestinal Dysfunction COMPLETED NCT04143269
Non-invasive transcutaneous vagus nerve stimulation DEVICE Approved Gastrointestinal Dysfunction COMPLETED NCT04143269
sham gammaCore Sapphire DEVICE Approved Post-Traumatic Headache WITHDRAWN NCT04071743
non-invasive Vagus Nerve Stimulator DEVICE Approved Ischemic Stroke COMPLETED NCT04050501
gammaCore Sapphire DEVICE Approved Post-Traumatic Headache WITHDRAWN NCT04071743
non-invasive vagus nerve stimulation DEVICE Approved Migraine WITHDRAWN NCT03787238
Gammacore sham device DEVICE Approved Stroke, Acute COMPLETED NCT03733431
Gammacore device DEVICE Approved Stroke, Acute COMPLETED NCT03733431
gammaCore Sapphire Sham DEVICE Approved Migraine Disorders COMPLETED NCT03716505
gammaCore Sapphire active DEVICE Approved Migraine Disorders COMPLETED NCT03716505
Sham Device DEVICE Approved Raynaud Phenomenon TERMINATED NCT03869008
GammaCore Device DEVICE Approved Painful Chronic Pancreatitis COMPLETED NCT03357029
gammaCore sham device DEVICE Phase PHASE1 Traumatic Brain Injury COMPLETED NCT02974959
gammaCore active device DEVICE Phase PHASE1 Traumatic Brain Injury COMPLETED NCT02974959
gammaCore-S Sham DEVICE Approved Migraine COMPLETED NCT02686034
gammaCore-S DEVICE Approved Migraine COMPLETED NCT02686034
gammaCore®-G DEVICE Approved Dyspepsia COMPLETED NCT02388269
gammaCore®-R Sham DEVICE Approved Migraine COMPLETED NCT02378844
gammaCore®-R DEVICE Approved Migraine COMPLETED NCT02378844
Sham GammaCore device DEVICE Approved Cluster Headache COMPLETED NCT01792817
GammaCore Sham Device DEVICE Approved Chronic Migraine COMPLETED NCT01667250
GammaCore Active Device DEVICE Approved Chronic Migraine COMPLETED NCT01667250
AlphaCore System DEVICE Approved Asthma TERMINATED NCT01385306
gammaCore DEVICE Approved Subarachnoid Hemorrhage, Aneurysmal RECRUITING NCT05103566
GammaCore DEVICE Approved Cluster Headache COMPLETED NCT01792817
AlphaCore device DEVICE Approved Chronic Obstructive Pulmonary Disease COMPLETED NCT01679314
AlphaCore Device DEVICE Approved Asthma WITHDRAWN NCT01923272
n-VNS DEVICE Approved Migraine COMPLETED NCT01532830
AlphaCore DEVICE Approved Asthma WITHDRAWN NCT01923272
ElectroCore RMS-1100 Resolution Motility System™ DEVICE Approved Ileus WITHDRAWN NCT00854074
Resolve Stimulator and Proximity Lead DEVICE Approved Asthma COMPLETED NCT00762931
Total products: 88